Why pain persists, and what actually has to change for it to resolve
Chronic pain is not a diagnosis. It is a signal, and in most people who have lived with it for months or years, that signal is being generated and sustained by a set of biological conditions that have very little to do with the body part that hurts. This is the reason so many patients cycle through anti-inflammatories, muscle relaxants, injections, and even surgery without lasting relief. The intervention silences the alarm without addressing what is setting it off.
The functional medicine approach begins from a different question. Instead of asking which drug or procedure will suppress this pain, it asks why this tissue is inflamed, why this nerve is sensitized, why this joint is degenerating faster than it is repairing, and why this nervous system has lost its ability to turn the volume down. The answers usually involve several overlapping drivers operating at once. Below are the ones I look for most often in practice.
1. Inflammation, and the Failure to Resolve It
Inflammation is the final common pathway of almost every chronic pain state. Pro-inflammatory cytokines such as TNF-alpha, IL-1 beta, and IL-6, along with prostaglandins produced through the COX pathway, directly lower the firing threshold of peripheral nociceptors. Tissues that would normally be silent begin to report. Sustained input of this kind eventually remodels the spinal cord and brain in a process called central sensitization, at which point pain becomes amplified and widespread, and the original injury is no longer required to keep it going.
What is often missed is that inflammation is supposed to be a self-limiting process with a built-in off switch. Resolution is active, not passive. It is orchestrated by specialized pro-resolving mediators, or SPMs, many of which are derived from the omega-3 fatty acids EPA and DHA and include the resolvins, protectins, and maresins. These molecules stop neutrophil recruitment, promote macrophage clearance of cellular debris, and switch tissue back toward repair. Many chronic pain patients are not suffering from too much inflammatory initiation so much as from too little resolution. A diet dominated by omega-6 linoleic acid from industrial seed oils, with minimal marine omega-3 intake, starves the body of the raw material for this off switch. Correcting the omega-6 to omega-3 ratio and, in some cases, supplementing SPMs directly, is a different strategy than simply blocking COX enzymes, and a more physiologic one. Plasma and red blood cell fatty acid analysis reveal the omega-6 to omega-3 ratio.
2. Oxidative Stress
Reactive oxygen and nitrogen species are not merely markers of tissue damage. They are active participants in pain signaling. Oxidants sensitize TRPV1 and TRPA1 ion channels on sensory neurons, promote lipid peroxidation of cell membranes, degrade hyaluronic acid in synovial fluid, activate NF-kB, and drive the release of matrix metalloproteinases that break down cartilage and intervertebral disc tissue. Oxidative stress and inflammation are a self-reinforcing loop: each generates the other.
Assessment includes markers of lipid peroxidation and DNA oxidation along with an evaluation of antioxidant capacity, particularly glutathione status. Repletion is rarely accomplished with a single antioxidant. The network requires adequate glutathione precursors, selenium, zinc, manganese, riboflavin, and a steady dietary supply of polyphenols, which work largely by upregulating the Nrf2 pathway and the body’s own antioxidant enzyme systems rather than by scavenging free radicals directly. Interventions are best personalized based on results of functional medicine tests like the Vibrant Wellness Oxidative Stress profile.
3. Mitochondrial Dysfunction
Muscle relaxation is an energy-dependent process. Calcium is pumped back into the sarcoplasmic reticulum by ATP-driven pumps, and when cellular energy production falters, muscle fibers cannot fully release. This is one plausible mechanism behind the persistent tight bands and tender points seen in myofascial pain and fibromyalgia. Nerve tissue is likewise energetically expensive, and damaged mitochondria in sensory neurons generate excess superoxide and promote spontaneous ectopic firing, a well-documented feature of neuropathic pain.
Mitochondrial support in this setting can include coenzyme Q10, acetyl-L-carnitine, alpha-lipoic acid, riboflavin, magnesium, and B vitamins, with attention paid to removing the mitochondrial toxins discussed below. Alpha-lipoic acid has the strongest human evidence of this group, primarily in diabetic peripheral neuropathy. The evidence for the others in chronic pain specifically is more mechanistic than clinical. The Vibrant Wellness Organic Acids analysis gives insight to mitochondrial function and elucidates which nutrients are most in need. Vibrant’s Cellular Zoomer is the name of the discounted combination profile consisting of the Oxidative Stress and Organic Acid analyses.
4. Blood Sugar Fluctuation and Insulin Resistance
Blood sugar instability contributes to pain from both directions. Reactive hypoglycemia triggers a surge of adrenaline and cortisol, which increases muscle tension, heightens anxiety, disturbs sleep, and lowers pain tolerance. Hyperglycemia and hyperinsulinemia, at the other end, drive inflammation, endothelial dysfunction, polyol pathway flux, and glycation. Insulin resistance is now recognized as an independent risk factor for osteoarthritis, low back pain, frozen shoulder, carpal tunnel syndrome, and painful peripheral neuropathy, and the association is not explained by body weight alone.
A fasting glucose within the laboratory reference range tells you very little. Fasting insulin, HbA1c, and especially continuous glucose monitoring reveal the postprandial excursions and the overnight instability that standard testing misses entirely. Watching one’s own glucose curve in response to real meals is also, in my experience, the single most persuasive educational tool available in clinical nutrition.
5. Glycation and Dietary Advanced Glycation End Products
When sugars react non-enzymatically with proteins and lipids, the result is advanced glycation end products, or AGEs. These matter enormously in musculoskeletal pain because the tissues most affected are the long-lived structural proteins: collagen in tendon, ligament, cartilage, fascia, and the annulus of the intervertebral disc. Collagen turns over slowly, so it accumulates crosslinks over time. Crosslinked collagen is stiffer, more brittle, less hydrated, and less able to distribute mechanical load, which means it tears more easily and heals more slowly. AGE accumulation in cartilage is strongly associated with the stiffness and degeneration of osteoarthritis, and AGE accumulation in disc tissue with degenerative disc disease.
AGEs also signal. Binding of AGEs to the receptor for advanced glycation end products, RAGE, activates NF-kB and generates both inflammation and oxidative stress, closing yet another self-amplifying loop. RAGE is expressed on sensory neurons as well, providing a direct route from glycation to nociception.
Endogenous AGE formation is driven by glycemic exposure, but a substantial portion of the body burden comes from the diet. Dry, high-heat cooking of protein and fat rich foods, such as grilling, broiling, roasting, frying, and searing, generates far more AGEs than moist, lower-temperature methods such as steaming, poaching, stewing, boiling, and slow cooking. Marinating in acidic media such as vinegar or lemon juice before cooking meaningfully reduces AGE formation, as does keeping cooking temperatures down and cooking times shorter. Human trials of AGE-restricted diets have shown reductions in inflammatory and oxidative stress markers and improvements in insulin sensitivity, though trials with pain as a primary endpoint are still lacking. I consider dietary AGE reduction a high-value, low-risk intervention with a strong mechanistic rationale and a still-developing clinical evidence base.
6. Dysbiosis, Intestinal Permeability, and Metabolic Endotoxemia
The gut is a major and frequently overlooked generator of systemic pain, which I strongly prioritize. An unfavorable microbial community produces fewer short chain fatty acids, particularly butyrate, which the colonic lining depends on for energy and which has direct anti-inflammatory and barrier-strengthening effects. When barrier integrity fails, bacterial cell wall debris – endotoxin such as lipopolysaccharide (LPS), crosses into circulation. LPS binds TLR4 on immune cells and on glial cells within the nervous system, producing a low-grade systemic inflammatory state known as metabolic endotoxemia. Metabolic endotoxemia appears to be extremely common and has wide ranging biological effects, being implicated in virtually all the degenerative diseases and biological aging. Endotoxemia should be at the top of the list of causes of any chronic inflammatory state. LPS activation of TLR4 on microglia is one of the better-characterized mechanisms of central sensitization and is a plausible link between gut health and widespread pain.
The clinical overlap supports this. Irritable bowel syndrome, small intestinal bacterial overgrowth, and fibromyalgia co-occur at rates far above chance. Ankylosing spondylitis, psoriatic arthritis, and rheumatoid arthritis all show characteristic microbiome alterations and increased intestinal permeability. Evidence also links dysbiosis and endotoxemia with osteoarthritis. Assessment includes comprehensive stool analysis, breath testing for SIBO where indicated, and markers of barrier function such as zonulin, occludin, and LPS antibodies. I use the GutID stool analysis to assess the microbiome and antibody blood tests for leaky gut markers from Vibrant Wellness and KBMO labs.
7. Chronic and Stealth Infections
Persistent pathogen burden is one of the most frequently missed drivers of unexplained widespread pain. Borrelia burgdorferi and its common coinfections, Epstein-Barr virus and other herpesviruses capable of reactivating under chronic stress and immune suppression, parvovirus B19, enteroviruses, Helicobacter pylori, and periodontal pathogens such as Porphyromonas gingivalis all sustain immune activation long after the acute phase has passed. Periodontal disease deserves particular emphasis because it is common, silent, and mechanistically well characterized, with P. gingivalis capable of citrullinating host proteins and thereby contributing to the autoimmunity of rheumatoid arthritis. Bristle Lab offers a salivary assessment to characterize the oral microbiome.
The mechanisms overlap with everything already described. Persistent infection maintains cytokine production, generates oxidative stress, impairs mitochondrial function, and in the case of molecular mimicry can initiate autoimmunity against host tissue. Some pathogens are directly neurotropic and establish latency within sensory ganglia. Post-viral syndromes belong in this category as well, and the long COVID population has substantially enlarged the group of patients presenting with widespread pain, small fiber neuropathy, dysautonomia, and post-exertional symptom worsening.
Testing requires realism. Standard Lyme serology has meaningful sensitivity limitations in late disseminated disease, and several specialty laboratory panels marketed for chronic infection have variable and sometimes poor independent validation. I use serology and PCR from Vibrant Wellness laboratory and pay close attention to exposure history and symptom pattern.
8. Immune Dysregulation, Autoimmunity, and Mast Cell Activation
This is distinct from inflammation considered as a general state. A meaningful subset of patients carrying a fibromyalgia label have demonstrable small fiber neuropathy on skin biopsy, and within that group some have autoantibodies against FGFR3 or trisulfated heparin disaccharide, making the condition an immune-mediated and potentially treatable neuropathy rather than a diagnosis of exclusion. Early inflammatory arthritis, polymyalgia rheumatica, and seronegative spondyloarthropathy are likewise misidentified as mechanical or idiopathic pain with some regularity. In 2021, a research group reported that immunoglobulin G from fibromyalgia patients transferred to mice reproduced pain sensitivity and reduced nerve fiber density in the recipients, which is a striking result. Independent replication remains limited, and I present it as an important line of investigation rather than settled science.
Mast cells belong in this discussion because they sit immediately adjacent to peripheral nerve endings and degranulate onto them, releasing histamine, tryptase, prostaglandin D2, and nerve growth factor, all of which sensitize nociceptors directly. Mast cell activation syndrome overlaps heavily with fibromyalgia, interstitial cystitis, irritable bowel syndrome, and migraine, and it should be suspected when pain travels with flushing, urticaria, food and chemical reactivity, and unpredictable multi-system flares. Laboratory confirmation is genuinely difficult, since tryptase, N-methylhistamine, and prostaglandin metabolites must be captured near a flare and handled carefully, so a supervised low-histamine trial together with mast cell stabilizing compounds such as quercetin and luteolin often functions as both test and treatment.
9. Toxic Burden
Environmental toxicants contribute to pain through several mechanisms simultaneously. Heavy metals such as lead, mercury, cadmium, and arsenic deplete glutathione, inhibit sulfhydryl-dependent enzymes, and poison mitochondrial respiration. Organic solvents, pesticides, phthalates, bisphenols, and mold-derived mycotoxins add inflammatory, neurotoxic, endocrine-disrupting, and immune-dysregulating effects. Mycotoxin exposure in water-damaged buildings deserves particular attention in patients presenting with widespread pain, fatigue, and cognitive symptoms that have resisted every other explanation.
Testing may include blood and urine metals, provoked or unprovoked depending on the question being asked, urinary organic pollutant and mycotoxin panels, and functional markers of detoxification capacity. Intervention emphasizes exposure reduction first, since no detoxification protocol can outrun ongoing exposure, followed by cellular support such as phosphatidylcholine to repair membranes, and targeted nutrition to support phase I, phase II, and phase III elimination pathways and adequate binding and excretion.
10. Nutrient Deficiencies and Other Nutritional Factors
Multiple nutrient insufficiencies produce or amplify pain directly. Vitamin D deficiency is associated with diffuse musculoskeletal pain, and while supplementation trials in unselected populations have been unimpressive, correction in genuinely deficient patients often helps. Magnesium is required for hundreds of enzymatic reactions, functions as a natural NMDA receptor antagonist, and is depleted by chronic stress, so insufficiency both increases muscle tension and lowers the threshold for central sensitization. Vitamin B12, folate, and vitamin B6 are essential for myelin integrity and neurological function, and B12 deficiency is a genuinely reversible cause of neuropathic pain that is routinely missed because the serum reference range is too permissive. Methylmalonic acid and homocysteine are far more sensitive indicators.
Beyond correcting deficiency, certain nutritional compounds modulate pain pathways pharmacologically. Curcumin, boswellia, ginger, and palmitoylethanolamide have reasonable human trial support in osteoarthritis and in some neuropathic states, and glucosamine, chondroitin, collagen peptides, and undenatured type II collagen have their own literature with mixed but not negligible results. Protein adequacy also matters more than most patients realize, since the amino acids required for connective tissue repair and neurotransmitter synthesis cannot be manufactured out of nothing.
11. Medication Effects and Iatrogenic Contributors
Some chronic pain is caused or perpetuated by its own treatment. Opioid-induced hyperalgesia, driven by glial activation and NMDA receptor upregulation, produces a paradoxical increase in pain sensitivity over time, and it compounds the testosterone suppression noted later in this article. Statins cause myopathy in a meaningful minority of users and deplete coenzyme Q10, which is required by the same muscle mitochondria. Aromatase inhibitors produce arthralgia in a large fraction of the women taking them. Fluoroquinolone antibiotics are directly mitochondrially toxic and are associated with tendinopathy and tendon rupture that can persist long after the course is finished. Long-term NSAID use impairs cartilage matrix synthesis and damages the intestinal barrier, which loops back to the endotoxemia described earlier.
Drug-induced nutrient depletion is the quieter version of the same problem. Proton pump inhibitors reduce absorption of vitamin B12, magnesium, and calcium, metformin depletes B12, diuretics waste magnesium, potassium, and zinc, and corticosteroids degrade both bone and muscle. Each of these produces symptoms indistinguishable from the pain syndrome the patient came in with. This category is worth reviewing early in every case because it is common, inexpensive to identify, and frequently reversible. Nothing here is an argument for stopping a prescribed medication independently, and any change belongs in a conversation with the prescribing physician.
12. Chronic Low-Grade Metabolic Acidosis
The typical modern diet, high in animal protein, grains, and ultra-processed foods, and low in potassium-rich fruits and vegetables, produces a net acid load. Blood pH is defended tightly, but that defense has costs: buffering draws on skeletal mineral reserves, increases urinary calcium and magnesium loss, raises cortisol, and promotes muscle protein breakdown. Each of these has obvious relevance to musculoskeletal pain, bone quality, and sarcopenia.
First-morning urinary pH readings, along with serum bicarbonate and the anion gap, help characterize acid load. Intervention is straightforward and consists largely of increasing vegetable and fruit intake and, where appropriate, supplying alkalizing mineral salts. It should be said plainly that the clinical trial evidence here is thin. A small number of studies of alkaline mineral supplementation in chronic low back pain and in rheumatoid arthritis have reported symptomatic improvement, but the literature is limited and the mechanism remains partly theoretical.
13. Hormone Imbalances
Hormones set the background gain on pain perception and on tissue repair. Cortisol dysregulation is the most common finding: an early hyperresponsive phase followed by a blunted, flattened rhythm in which the anti-inflammatory and diurnal signaling functions of cortisol are lost. Hypothyroidism, including the subclinical and low T3 patterns that a TSH-only workup will not detect, produces myalgia, stiffness, delayed reflexes, and impaired tissue healing. Estrogen influences nociception directly and helps explain why female pain conditions frequently change with the menstrual cycle and worsen through perimenopause. Low testosterone in either sex reduces muscle mass, impairs repair capacity, and is associated with greater pain severity, and opioid therapy itself suppresses testosterone, which is a badly underappreciated contributor to worsening pain on long-term opioid treatment. Growth hormone and IGF-1 deficiency has been documented in a subset of fibromyalgia patients, and insulin belongs on this list as well.
Salivary or dried urine steroid profiling with a full diurnal cortisol curve and metabolite assessment, a complete thyroid panel including free T3, reverse T3, and antibodies, and sex hormone evaluation with metabolites give a far more actionable picture than the standard screening panel.
14. Impaired Circulation
Tissue that is not perfused cannot heal, and ischemia is itself painful. Local hypoxia within taut muscle bands is a central feature of the trigger point, where sustained contraction compresses the very capillaries the tissue depends on, producing an energy crisis that maintains the contraction. On a larger scale, endothelial dysfunction with reduced nitric oxide availability, arterial stiffness, elevated fibrinogen and blood viscosity, and venous congestion all reduce oxygen delivery and impair the clearance of inflammatory metabolites. Impaired lumbar arterial perfusion is associated with disc degeneration, a structure that is already at a nutritional disadvantage because it is largely avascular and depends on diffusion.
Nitric oxide support through dietary nitrate and targeted supplements, correction of the metabolic drivers of endothelial dysfunction, movement, heat, manual therapy, and where appropriate photobiomodulation and other circulatory modalities all address this component.
15. Food Sensitivities
Distinct from IgE-mediated allergy, delayed food reactions can drive systemic inflammation and pain. The strongest evidence comes from migraine, where randomized trials of IgG-guided elimination diets have shown reductions in headache frequency, and from irritable bowel syndrome, where similar approaches have produced symptom improvement. Gluten sensitivity outside of celiac disease can present with joint pain and neurological symptoms, and dairy proteins, eggs, corn, soy, and nightshades are frequent offenders in individual patients.
IgG testing is genuinely controversial and elevated IgG can reflect exposure rather than pathology. The KBMO Food Inflammation Test measures more specific markers of inflammation, IgG 1-4 and C3d. This minimizes false positive results. Histamine intolerance, salicylate and oxalate sensitivity, and FODMAP reactivity are separate mechanisms that can masquerade as food sensitivity and should be considered when the pattern does not fit.
16. Altered Body Composition
Excess adipose tissue is not inert padding. It is an active endocrine and immune organ that secretes leptin, resistin, TNF-alpha, and IL-6 while lowering the anti-inflammatory adipokine adiponectin. This is why obesity increases pain even in non-weight-bearing joints such as the hands, a finding that cannot be explained mechanically. At the same time, loss of muscle mass, whether frank sarcopenia or the sarcopenic obesity in which muscle is lost while fat is gained, removes the dynamic stabilization that joints depend on and shifts load onto passive structures. Fat infiltration into muscle, particularly the lumbar multifidus, is one of the more reliable imaging correlates of chronic low back pain.
Body composition analysis is more informative than weight or BMI. The therapeutic target is not simply weight loss but the simultaneous preservation or building of lean mass, which requires adequate protein, resistance training, and correction of the hormonal and inflammatory environment that is driving the loss.
17. Inadequate Exercise
Exercise is not merely a way to strengthen the tissues around a painful joint. It is a metabolic and immunologic intervention. Acute exercise induces the production of specialized pro-resolving mediators, the same resolvin and maresin family described earlier, meaning that movement literally supplies the signal that terminates inflammation. Exercise also produces exercise-induced hypoalgesia, engages descending inhibitory pathways, releases anti-inflammatory myokines including IL-10 and IL-1 receptor antagonist, stimulates mitochondrial biogenesis, improves insulin sensitivity and circulation, raises BDNF, and helps clear senescent cells.
Deconditioning, by contrast, is not neutral. It is an active pain-generating state. Fear-avoidance behavior after an injury sets up a spiral in which reduced movement produces stiffness, weakness, worse metabolic health, and more pain, which justifies further avoidance. Breaking that cycle usually requires a graded and initially very modest program, since the goal early on is to restore confidence and tolerance rather than to achieve any particular fitness target.
18. Cellular Senescence
Senescent cells stop dividing but refuse to die, and they secrete a characteristic mixture of inflammatory cytokines, chemokines, and matrix-degrading proteases known as the senescence-associated secretory phenotype. This phenotype spreads senescence to neighboring cells and actively degrades surrounding tissue. Senescent chondrocytes accumulate in osteoarthritic cartilage, senescent cells accumulate in degenerating intervertebral discs, and in animal models, clearing them reduces both degeneration and pain behavior.
This is an area where the biology is compelling and the human clinical evidence is still immature. Exercise, caloric moderation, glycemic control, and reduction of oxidative and toxic burden all reduce senescent cell formation, and these are worth doing regardless. Senolytic compounds including fisetin and quercetin are under active investigation.
19. Chronic Stress and Nervous System Dysregulation
Psychological stress is not an alternative explanation for pain offered when the workup is negative. It is a physiological driver with measurable effects. Chronic stress dysregulates the HPA axis, promotes systemic inflammation, increases muscle tension, impairs digestion and barrier function, disrupts sleep, and weakens the descending pathways that normally inhibit pain signals at the level of the spinal cord. Adverse childhood experiences are a documented risk factor for adult chronic pain syndromes, and pain catastrophizing predicts pain outcomes better than imaging findings do.
This does not mean the pain is imagined. It means the nervous system is a modifiable part of the mechanism. Approaches that restore autonomic balance, including breath training, meditation, cognitive and pain neuroscience education, graded exposure, vagal support, time outdoors, and adequate social connection, change the physiology and belong in the plan alongside everything else described here.
20. Autonomic Dysfunction and Vagal Tone
Sympathetic dominance with parasympathetic withdrawal is measurable, and reduced heart rate variability has been documented across fibromyalgia, rheumatoid arthritis, chronic low back pain, and migraine. The vagus nerve is the reason this matters mechanistically rather than metaphorically. Efferent vagal signaling releases acetylcholine that binds the alpha-7 nicotinic receptor on macrophages, suppressing TNF-alpha production. This cholinergic anti-inflammatory pathway means the parasympathetic nervous system functions as a genuine brake on systemic inflammation, and a person with low vagal tone has lost part of that brake.
Traffic on the vagus runs predominantly upward, with roughly eighty percent of its fibers carrying afferent information from the viscera to the brainstem. This is the anatomical basis of the gut and pain relationship described earlier, and it explains why interoceptive accuracy, digestive function, and pain perception tend to move together. Separately, after nerve injury, nociceptors can upregulate adrenergic receptors and begin responding to circulating catecholamines, producing sympathetically maintained pain, the mechanism behind complex regional pain syndrome. Orthostatic intolerance and postural orthostatic tachycardia syndrome also cluster with hypermobility and mast cell activation, a triad worth screening for deliberately in younger patients with widespread pain and fatigue.
Assessment is inexpensive. Morning heart rate variability trends from a consumer wearable are adequate for tracking, and a ten minute orthostatic stand test with serial heart rate and blood pressure readings identifies most cases of orthostatic intolerance in the office. On the intervention side, slow diaphragmatic breathing with a prolonged exhalation, ideally at around six breaths per minute, is the best-validated way to raise vagal tone acutely, and formal heart rate variability biofeedback has reasonable supporting trial evidence. Regular aerobic exercise and adequate sleep raise it durably. Non-invasive vagus nerve stimulation comes in two forms that should not be treated as interchangeable. Cervical stimulation, delivered by a handheld device held against the side of the neck over the vagus nerve where it runs in the carotid sheath, has the stronger regulatory standing. It has carried FDA clearance since 2017 for cluster headache, subsequently for the acute and preventive treatment of migraine, and most recently for paroxysmal hemicrania and hemicrania continua. Even there the evidence deserves an honest reading, since the two pivotal sham-controlled cluster headache trials did not meet their primary endpoints while still showing benefit within the episodic subgroup. Auricular stimulation, applied to the cymba conchae or tragus of the outer ear, is the form that dominates both the research literature and the consumer market, and it has been examined in fibromyalgia and broader pain states in small and heterogeneous trials that I would call promising rather than established. Neither approach has demonstrated efficacy for chronic widespread pain at a level that would justify recommending purchase as a primary intervention, and the inexpensive ear clips sold direct to consumers should not be assumed to reproduce the stimulation parameters used in the trials. Implanted vagal stimulation is not an appropriate treatment for general chronic pain. Humming, gargling, cold face immersion, and similar practices are harmless and popular but rest on much thinner evidence than their online reputation suggests.
21. Inadequate Sleep
Sleep is when repair happens. Growth hormone is released in pulses during slow wave sleep, tissue protein synthesis accelerates, glymphatic clearance removes metabolic waste from the central nervous system, and inflammatory signaling is downregulated. Deprive a healthy person of sleep, and pain thresholds fall within a single night. In longitudinal studies, poor sleep predicts the onset of chronic widespread pain more strongly than pain predicts the onset of poor sleep, which means sleep is not simply a casualty of the pain but frequently one of its causes.
Alpha wave intrusion into deep sleep is a classic finding in fibromyalgia. Obstructive sleep apnea deserves specific screening in any chronic pain patient, particularly one with morning headache, unrefreshing sleep, or hypertension, because untreated apnea generates intermittent hypoxia and a powerful inflammatory and oxidative load every night. Addressing circadian rhythm, light exposure, evening glycemic stability, magnesium status, and sleep environment usually produces more durable results than sedative medication, which suppresses the very sleep architecture that repair depends on.
22. Altered Biomechanics, Alignment, and Connective Tissue Integrity
None of the preceding sections is an argument that structure does not matter. It matters a great deal, but it matters in context. Faulty mechanics concentrate load on tissues that were not designed to bear it, and if that tissue is also glycated, poorly perfused, energy-depleted, and inflamed, it will fail at a fraction of the load a healthy tissue would tolerate. This is precisely why two people with identical imaging findings can have entirely different pain experiences.
The mechanical evaluation includes gait and foot mechanics, leg length, pelvic and spinal alignment, joint mobility and restriction, movement pattern quality and motor control, muscle length and strength balance, breathing mechanics, and the ergonomics of the positions a person actually spends their day in. Correcting these through adjustment, manual therapy, targeted rehabilitative exercise, orthotic support where indicated, and workstation and habit modification removes the mechanical provocation while the biochemical work removes the tissue vulnerability. Either alone is usually insufficient. Together they are frequently transformative.
Connective tissue quality belongs in this section as well, because some patients are not misaligned so much as inherently unstable. Hypermobility spectrum disorder and hypermobile Ehlers-Danlos syndrome involve collagen that is too compliant, producing joint instability, repeated microtrauma, subluxation, and impaired proprioception, since the receptors reporting joint position sit in tissue that is not holding position. These patients are commonly told for years that nothing is wrong, and they are frequently the same patients carrying the dysautonomia and mast cell findings described in earlier sections. A Beighton score takes two minutes to perform. The management implication is important and counterintuitive: these joints need stabilization, proprioceptive retraining, and controlled strengthening rather than the stretching and aggressive mobilization that feel good in the moment and worsen the underlying instability over time.
Putting It Together
These twenty-two factors are not a menu from which one item is selected. They form a network, and in a person with long-standing pain, several of them are usually reinforcing each other. Insulin resistance drives glycation and inflammation. Inflammation disrupts sleep. Poor sleep worsens insulin resistance and lowers pain threshold. Pain reduces movement. Reduced movement lowers SPM production and accelerates muscle loss, which increases mechanical strain and metabolic dysfunction. Every loop in that description runs in both directions, which is discouraging when the loops are running the wrong way and extremely encouraging when they begin to turn.
Clinically, the work proceeds by identifying which drivers are actually operative in the individual in front of me, using history, examination, and targeted laboratory assessment rather than a fixed protocol. Testing typically includes an expanded metabolic and inflammatory panel, comprehensive nutrient status, organic acids for mitochondrial and microbial metabolites, gastrointestinal analysis, full hormone profiling, oxidative stress and glycation markers, toxic element and chemical exposure assessment where the history suggests it, and body composition. The plan that follows is sequenced rather than simultaneous, because a person in pain has finite capacity for change, and the highest-leverage interventions should come first.
Progress in this model is usually not linear and rarely instantaneous. Collagen crosslinks accumulated over decades do not disappear in a month, and a sensitized nervous system takes time to recalibrate. What patients typically notice first is that flares become shorter and less severe, then less frequent, and then that they have gone some time without thinking about the pain at all. That is what resolution actually looks like when it comes from repairing the underlying biology rather than from silencing the signal.
This article is for educational purposes and does not constitute medical advice or replace evaluation by a qualified healthcare provider. If you are living with chronic pain and want to understand what is driving it, a comprehensive functional medicine evaluation is the place to start.